ITCI - Intracellular Th - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITCI is currently covered by 10 analysts with an average price target of $142.87. This is a potential upside of $16.67 (13.21%) from yesterday's end of day stock price of $126.2.

Intracellular Th's activity chart (see below) currently has 120 price targets and 149 ratings on display. The stock rating distribution of ITCI is 92% BUY and 8% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 98.32% with an average time for these price targets to be met of 570.47 days.

Highest price target for ITCI is $130, Lowest price target is $74, average price target is $142.87.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 13-Jan-2025. First documented stock forecast 23-Dec-2014.

Currently out of the existing stock ratings of ITCI, 69 are a BUY (92%), 6 are a HOLD (8%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$100

$-26.2 (-20.76%)

$100

7 days ago
(13-Jan-2025)

24/25 (96%)

$-27.71 (-21.70%)

165

Buy

$89

$-37.2 (-29.48%)

$81

2 months 16 days ago
(04-Nov-2024)

9/9 (100%)

$2.02 (2.32%)

43

Buy

$95

$-31.2 (-24.72%)

$80

3 months 9 days ago
(11-Oct-2024)

4/4 (100%)

$19.24 (25.40%)

323

Buy

$108

$-18.2 (-14.42%)

$106

3 months 16 days ago
(04-Oct-2024)

21/21 (100%)

$35.11 (48.17%)

244

Buy

$130

$3.8 (3.01%)

$130

4 months ago
(20-Sep-2024)

26/29 (89.66%)

$52.39 (67.50%)

497

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITCI (Intracellular Th) average time for price targets to be met?

On average it took 570.47 days on average for the stock forecasts to be realized with a an average price target met ratio 98.32

Which analyst has the current highest performing score on ITCI (Intracellular Th) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on ITCI (Intracellular Th)?

Sumant Kulkarni works at CANACCORD and has 9 price targets and 9 ratings on ITCI

Which analyst is the currently most bullish on ITCI (Intracellular Th)?

Charles Duncan with highest potential upside - $3.8

Which analyst is the currently most reserved on ITCI (Intracellular Th)?

Edward Nash with lowest potential downside - -$98.2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?